Cytosorbents Corp financial data

Symbol
CTSO on Nasdaq
Location
305 College Road East, Princeton, NJ
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 7, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 230 % +27.6%
Quick Ratio 33.7 % +12.5%
Debt-to-equity 285 % +85.8%
Return On Equity -78.3 % +40.6%
Return On Assets -20.4 % +60.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 62.8M shares +15.3%
Common Stock, Shares, Outstanding 62.6M shares +15.3%
Entity Public Float 37.1M USD -74.2%
Common Stock, Value, Issued 63K USD +16%
Weighted Average Number of Shares Outstanding, Basic 62.6M shares +15.3%
Weighted Average Number of Shares Outstanding, Diluted 67.2M shares +23.7%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 9.72M USD -35.4%
Operating Income (Loss) -16.1M USD +35.7%
Nonoperating Income (Expense) 4.5M USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -17.8M USD +38.2%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -9.87M USD +62.3%
Earnings Per Share, Basic 0 USD/shares +65.4%
Earnings Per Share, Diluted 0 USD/shares +65.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 10.2M USD +20.6%
Accounts Receivable, after Allowance for Credit Loss, Current 7.74M USD -1.02%
Inventory, Net 3.71M USD -14.1%
Assets, Current 23M USD +4.7%
Property, Plant and Equipment, Net 8.47M USD -10.2%
Operating Lease, Right-of-Use Asset 11.2M USD -4.81%
Other Assets, Noncurrent 3.79M USD +0.47%
Assets 48M USD -10.2%
Accounts Payable, Current 3.39M USD +11.4%
Accrued Liabilities, Current 498K USD -41.5%
Contract with Customer, Liability, Current 361K USD
Liabilities, Current 9.84M USD +2.05%
Operating Lease, Liability, Noncurrent 12.2M USD -3.91%
Liabilities 36.4M USD +1.13%
Accumulated Other Comprehensive Income (Loss), Net of Tax -3.96M USD -282%
Retained Earnings (Accumulated Deficit) -304M USD -3.36%
Stockholders' Equity Attributable to Parent 11.6M USD -33.5%
Liabilities and Equity 48M USD -10.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.46M USD +28.3%
Net Cash Provided by (Used in) Financing Activities 6.83M USD
Net Cash Provided by (Used in) Investing Activities -47.2K USD +62.8%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 62.6M shares +15.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3.35M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 11.7M USD -21.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 506K USD +154%
Deferred Tax Assets, Valuation Allowance 48.3M USD +6.47%
Deferred Tax Assets, Gross 51.9M USD +5.74%
Operating Lease, Liability 12.7M USD -3.15%
Depreciation 306K USD -10.7%
Payments to Acquire Property, Plant, and Equipment 2.12K USD -95.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -15.7M USD +38%
Lessee, Operating Lease, Liability, to be Paid 21.6M USD -7.2%
Property, Plant and Equipment, Gross 13.5M USD
Operating Lease, Liability, Current 495K USD +20.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.78M USD +3.58%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.74M USD +3.58%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 8.92M USD -12.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.82M USD +3.58%
Deferred Tax Assets, Operating Loss Carryforwards 39.3M USD +6.73%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 2.2M USD +4.11%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.86M USD +3.62%
Operating Lease, Payments 1.82M USD -16.7%
Additional Paid in Capital 319M USD +3.29%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 3.59M USD -3.25%
Share-based Payment Arrangement, Expense 3.66M USD -15.5%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%